Khalid Ahmed Al-Anazi

King Fahad Specialist Hospital

Dr. Khalid Ahmed Al-Anazi is a consultant Hemato-Oncologist and the Chairman of the Department of Adult Hematology and Hematopoietic Stem Cell Transplantation (HSCT) at King Fahad Specialist Hospital (KFSH) in Dammam, Saudi Arabia. He graduated from the college of medicine, King Saud University (KSU) in Riyadh in the year 1986. After having his Boards in Internal Medicine, he trained in clinical hematology and HSCT at King’s College Hospital, University of London, U.K. Dr. Al-Anazi has 4 year experience in internal medicine and 26 year experience in adult clinical hematology and HSCT at Riyadh Armed Forces Hospital then King Faisal Specialist Hospital and Research Centre (KFSH&RC) in Riyadh, King Khalid University Hospital and College of Medicine, KSU in Riyadh and KFSH in Dammam, Saudi Arabia. Dr. Al-Anazi received the award of the best teacher in the Department of Medicine, at the College of Medicine and KKUH in Riyadh in the year 2014. He established the adult HSCT program at KFSH in Dammam in the year 2010. He has more than 85 publications including retrospective studies, review articles, book chapters and electronic books and he is a reviewer for 23 international medical journals. Dr. Al-Anazi is the Editor-in-Chief of the Journal of Stem Cell Biology and Transplantation and the Journal of Molecular Genetics and Medicine in addition to being Associate Editor for 26 other medical journals in HSCT, hematology, cancer and infectious diseases.

1books edited

9chapters authored

Latest work with IntechOpen by Khalid Ahmed Al-Anazi

This book is a comprehensive overview of the recent developments in the clinical and research fields of multiple myeloma. It is divided into three main sections that cover a wide range of topics, including: epidemiology and pathogenesis of the disease, genetic targets and pathways, resistance to novel therapies, angiogenesis and anti-angiogenesis, hematopoietic stem cell transplantation, role of radiology and radiotherapy in myeloma, infectious complications, and management of multiple myeloma in resource-poor countries.

Go to the book